CSChun Song

Chun Song

*This is an algorithmically generated author record based on publicly available information.

Chun Song has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Bing-Xing Pan

    Department of Pathology, The First Affiliated Hospital and Institute of Biomedical Innovation, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China

    1 shared publication
  • Chiye Ma

    Department of Bariatric and Metabolic Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

    1 shared publication
  • Guanghui Wang

    Department of Breast Surgery, Guizhou Provincial People’s Hospital, Guiyang, People’s Republic of China

    1 shared publication
  • Guo-Huang Fan

    Excecutive Office, Immunophage Biotech Co., Ltd., Shanghai, China

    1 shared publication
  • Han Yan

    Laboratory of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing 100871, China

    1 shared publication
  • Hanming Wang

    Laboratory of Nucleic Acid Technology, Institute of Molecular Medicine, Peking University, Beijing, 100871, China

    1 shared publication

Latest Publications

  • Open Access

    SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression

    by Ximao Cui, Yanfen Cui, Tao Du, Xiaohua Jiang, Chun Song, Shun Zhang, Chiye Ma, Yun Liu, Qing Ni, Yuzhe Gao, et al.

    Introduction. Serine hydroxymethyltransferase 2 (SHMT2) has a critical role in serine-glycine metabolism to drive cancer cell proliferation. Yet, the function of SHMT2 in tumorigenesis, especially in human colorectal cancer (CRC) progression, remains largely unclear. Materials and Methods. CRC and paired normal samples were collected in the Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, and assessed by real-time polymerase chain reaction (qPCR) analysis, western blot (WB), and immunohistochemistry (IHC). Moreover, SHMT2 expression in human CRC cells was identified by qPCR and WB. The CRC cell proliferation, migration, and invasion after SHMT2 knockdown were explored through in vitro and in vivo assays. mRNA-seq assays were used to investigate the underlying mechanisms behind the SHMT2 function. Results. It was found that SHMT2 mRNA and protein were overexpressed in CRC tissue compared to the levels in normal mucosa. Positive expression of SHMT2 was significantly correlated with TNM stage and lymph node metastasis, and elevated expression of SHMT2 resulted as an independent prognostic factor in patients with CRC. SHMT2 knockdown impaired the proliferation of CRC in vitro and in vivo and induced cell cycle arrest by regulating UHRF1 expression. Conclusion. Taken together, our findings reveal that UHRF1 is a novel target gene of SHMT2, which can be used as a potential therapeutic strategy for CRC therapy.


  • AQR is a novel type 2 diabetes-associated gene that regulates signaling pathways critical for glucose metabolism

    by Chun Song, Han Yan, Hanming Wang, Yan Zhang, Huiqing Cao, Yiqi Wan, Lingbao Kong, Shenghan Chen, Hong Xu, Bingxing Pan, et al.